<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Benefit of ACE inhibitors in all patients with acute MI</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Benefit of ACE inhibitors in all patients with acute MI</h1>
<div class="graphic"><div class="figure"><div class="ttl">Benefit of ACE inhibitors in all patients with acute MI</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Reduction in deaths with the use of lisinopril or captopril (red and green bars) versus control (blue solid bars) after acute myocardial infarction in the GISSI-3 and ISIS-4 trials. The numbers in parentheses refer to the portion of mortality reduction attributable to the ACE inhibitor for each of the three time periods shown; approximately 30 percent of the total mortality reduction occurred within the first 24 hours following symptom onset, supporting the early use of these agents in acute myocardial infarction.</div><div class="graphic_reference">Data from Latini R, Maggioni AP, Flather M, et al. Circulation 1995; 92:3132.</div><div id="graphicVersion">Graphic 52159 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
